ViewRay’s MRI-Guided Radiation Therapy Debuts in Boston

0
104
viewray blog graphic
A ViewRay MRIdian Machine.

CLEVELAND, Oct. 7, 2019 /TheStockDork/ — The Dana-Farber/Brigham and Women’s Cancer Center in Boston will begin MRI-guided radiation therapy for cancer patients, it’s the first joint cancer program in New England to offer the treatment.

Using newly developed technology, doctors now have the ability to continually monitor MRI images while performing radiation therapy to targeted tumors.

viewray blog graphic
A ViewRay MRIdian Machine.

ViewRay, Inc. (VRAY)

ViewRay, Inc. produces the technology that makes this type of therapy possible. The Boston hospitals offering this treatment are using ViewRay’s MRIdian® Linac System. ViewRay designs, manufactures, and markets the system.

The company designed the system using its proprietary high-definition magnetic imaging system. MRIdian was conceived and built to be used in advanced radiological oncology treatments. The system addresses several unique challenges that used to make real-time imaging difficult, if not impossible.

Strong magnetic fields can interact with radiation beams and create problems for targeted treatments. Magnetic interference can cause beam distortion, skin toxicity, and other concerns. ViewRay’s design helps minimize or eliminate these problems.

Impact

The new machine will be used to treat a variety of different cancerous tumors. However, the treatment is most effective on soft tissue tumors and ‘highly-mobile’ tumors, like those found in lung cancer patients.

Raymond Mak, M.D., the lead radiation oncologist for MRI Guided Radiation Therapy at the Dana-Farber/Brigham and Women’s Cancer Center spoke highly of the new treatment. “This new technology offers substantial clinical benefit by providing greater resolution of soft tissue tumors, allowing for more precise tumor targeting and less radiation exposure; thus sparing healthy tissue,” Dr. Mak said in a ViewRay company press release, “This cutting-edge technology allows us to personalize and adapt each treatment in ways we never could before.”

The Company Line

ViewRay CEO and President, Scott Drake, also made a statement in the press release. Dana Farber/Brigham and Women’s is a world leader in adult and pediatric cancer treatment and research,” said Drake, “We share a common mission to eradicate cancer with the use of innovative technologies, and we look forward to further serving patients.” 

Ohio-based ViewRay is a NASDAQ-listed company with a market capitalization of over $480 million.

Chris Dios is an American writer and entrepreneur based in the Greater NYC area.

LEAVE A REPLY

Please enter your comment!
Please enter your name here